Rituximab Plus CEAC: No Survival Advantage in DLBCL
In the evolving landscape of oncology, particularly targeting hematological malignancies, innovative therapeutic strategies consistently attract significant attention. A recent pivotal ...
In the evolving landscape of oncology, particularly targeting hematological malignancies, innovative therapeutic strategies consistently attract significant attention. A recent pivotal ...
In a groundbreaking study published in the esteemed journal "Annals of Hematology," researchers led by Laura Osanno, along with her ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine